Inventor · Montpellier, FR

Gilles Gosselin

58Patents
29h-index
35Co-inventors
88Inventor score

Filing activity: Jun 22, 1982 → Nov 30, 2015

Most-cited inventions

PatentTitleAreaCited byStatus
US4476301A Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon Chemistry; Metallurgy 453 Expired
US7608600B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 144 Expired
US7365057B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections Chemistry; Metallurgy 95 Expired
US7635689B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 93 Expired
US7951789B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 69 Active
US7625875B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 67 Expired
US7456155B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 64 Expired
US7547704B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 64 Expired
US7192936B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 61 Expired
US6566344B1 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 61 Expired
US7138376B2 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Chemistry; Metallurgy 61 Expired
US7902202B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 60 Active
US7384924B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 59 Expired
US7582618B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 58 Active
US6395716B1 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 55 Expired
US7662798B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 55 Expired
US9211300B2 4′-fluoro nucleosides for the treatment of HCV Chemistry; Metallurgy 55 Active
US8680071B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 54 Active
US6444652B1 &bgr;-L-2'-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 52 Expired
US8637475B1 Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections Chemistry; Metallurgy 50 Active
US6569837B1 &bgr;-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 48 Expired
US8691788B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 46 Active
US6875751B2 3′-prodrugs of 2′-deoxy-β-L-nucleosides Chemistry; Metallurgy 45 Expired
US5955591A Phosphotriester oligonucleotides, amidites and method of preparation Emerging Cross-Sectional Technologies 39 Expired
US6124445A Phosphotriester oligonucleotides, amidities and method of preparation Emerging Cross-Sectional Technologies 36 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.